why choose us

First received: August 03, 2023

Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, CROSSOVER, FIRST-IN-HUMAN STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF PF-069

Brief Summary: The purposes of this study are:To see how the new medicine (PF-06954522) under study behave.And if there are any important side effects.A side effect is a reaction (expected or unexpected) to a medicine or treatment you take.The study will see how people feel after taking single increasing amount of the medicine by mouth.To measure the amount of study medicine in your blood after the medicine is taken by mouth.This study is seeking for participants who:are females of 18 to 65 years old and are not able to give…

Read more